Descrição

Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons.

Figure 22

Chart

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 22: Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)

<figure>
  <img src="" alt="Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons." />
  <figcaption>Figure 22. Multi-panel analysis results labeled (c) and (d) from the synbiotic IBS-D trial present additional symptom domain comparisons.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Evidências Relacionadas

Bifidobacterium longum para Irritable Bowel Syndrome (IBS)

Nota B · 4 estudos

Galactooligosaccharides (GOS) para Irritable Bowel Syndrome (IBS)

Nota B · 3 estudos

Lactobacillus acidophilus para Irritable Bowel Syndrome (IBS)

Nota B · 3 estudos

Fructooligosaccharides (FOS) para Irritable Bowel Syndrome (IBS)

Nota D · 2 estudos